Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

HealthRX vs Direct Meds

HealthRX
Graded #9

Higher grade

vs+4
Direct Meds
Graded #27

Lower grade

The verdict

HealthRX takes it — 86/100 to 82/100.

HealthRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A LegitScript-certified (#50087439) physician-supervised program that runs a rare oral GLP tablet alongside the usual injectables — compounded semaglutide from ~$189/mo, tirzepatide/GLP+GIP up to ~$349, with a brand Ozempic pass-through if you need it.

Assume any provider we list may compensate us — we may earn a commission at no cost to you. It never changes the WeighScore.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
85
85
Dose & formulationHealthRX +2
90
88
Clinical oversightHealthRX +7
87
80
Labs & monitoringHealthRX +4
82
78
FulfillmentHealthRX +6
86
80
Contract termsHealthRX +5
85
80
HealthRX · left barDirect Meds · right bar

The numbers

MetricHealthRXDirect Meds
WeighScore86/10082/100
GradeBB−
Scorecard rank#9#27
Semaglutide$189/mo$179/mo
Tirzepatide$349/mo$224/mo
CoverageNot publicly listedNot publicly listed
Brand-name accessYesCompounded only
Oral / sublingualYesYes
HealthRX

Graded #9 · B

Strengths

  • LegitScript-certified (#50087439) — a genuine, verifiable trust signal
  • Physician-supervised intake with licensed providers
  • Both molecules plus a rare oral GLP tablet option
  • Transparent flat monthly pricing, no insurance required

Where it loses points

  • Compounded semaglutide/tirzepatide is not FDA-approved
  • Some tiers are company-stated and the public site is thin
  • Brand Ozempic is a steep pass-through (~$1,299)
  • State count is not publicly listed
Direct Meds

Graded #27 · B−

Strengths

  • Rare oral/sublingual option in addition to injectable
  • All-inclusive pricing with no separate membership fee
  • Both molecules — semaglutide and tirzepatide
  • Intro promotional pricing near $147

Where it loses points

  • Compounded only — not FDA-approved
  • Pricing is company-stated, not independently live-verified
  • Newer and somewhat ambiguous (operates across multiple domains)
  • States served are not disclosed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 31 providers, CoreAge Rx grades highest at 94/100 (A). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard